ES-Bliss 10 Tablet contains Escitalopram Oxalate 10 mg, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram functions by increasing the availability of serotonin, a neurotransmitter, in the central nervous system, thereby helping to restore the balance of serotonin and improve mood and anxiety symptoms. This medication is prescribed to alleviate symptoms such as persistent sadness, loss of interest, excessive worry, and tension. ES-Bliss 10 is administered orally, typically once daily, with or without food, and dosage adjustments may be necessary based on clinical response and tolerability. It is essential to adhere to the prescribed regimen and avoid abrupt discontinuation to prevent withdrawal symptoms. Common adverse effects include nausea, headache, insomnia, fatigue, and dry mouth, while serious side effects may involve serotonin syndrome, suicidal ideation, and QT interval prolongation. Caution is advised in patients with a history of bipolar disorder, seizures, or cardiac conditions. ES-Bliss 10 should not be co-administered with monoamine oxidase inhibitors (MAOIs) or other serotonergic agents without appropriate washout periods. Regular monitoring by a healthcare professional is recommended to assess therapeutic efficacy and safety during treatment.